tim@emorningcoffee.com
Week ended Oct 11, 2024: more record highs for US stocks
CPI slightly hotter than expected, and earnings off to a good start. Yields continue to back up, US stocks at record high close.
top of page
Home: Welcome
My view on what's going on in the financial markets and the global economy, and a few other things that might interest me from time to time.
Search
tim@emorningcoffee.com
4 days ago9 min
Portfolio update: 3Q2024
This is the update of my personal portfolio for the most recent quarter ended September 30, 2024.
350
tim@emorningcoffee.com
Oct 55 min
Week ended October 4, 2024: soft landing in sight
Risk remains asymmetrical to the downside, but a robust US jobs report cheered risk investors on Friday and sent UST yields sharply higher.
160
tim@emorningcoffee.com
Sep 2510 min
Three key election issues: immigration, inflation and abortion
There are many important issues in the US Presidential election, but none more so perhaps than immigration, inflation, and abortion.
430
tim@emorningcoffee.com
Jul 248 min
Portfolio update: 1H2024
This is an update of my personal portfolio performance in 2Q2024 and 1H2024, good on the surface but worse than the indices would suggest.
650
tim@emorningcoffee.com
Jun 256 min
US deficits / debt soar; should you care?
US deficits are soaring, along with US debt to finance the "exceptional growth" of the US. Can this continue?
660
tim@emorningcoffee.com
Jun 127 min
Midweek update: Apple, CPI/FOMC, GME
We have some US data coming that might matter today (CPI), but the FOMC will sit tight (also today). Discusses Apple's run and GameStop.
240
tim@emorningcoffee.com
May 214 min
Is fine wine a good investment?
The 2024 en primeur campaign for Bordeaux is just starting. But is fine wine really a good investment? I don't think so anymore.
2004
tim@emorningcoffee.com
Apr 108 min
Portfolio update: 1Q2024
This is an update about my personal portfolio during and at the end of 1Q2024. It also discusses performance which I consider disappointing.
730
tim@emorningcoffee.com
Mar 188 min
Anti-obesity medications: part 3, valuations of LLY and NVO
This is the 3rd and final article focused on anti-obesity drugs. It looks at valuations of shares of the two giants in this biz, LLY & NVO.
470
tim@emorningcoffee.com
Mar 147 min
Anti-obesity medications part 2: the duopoly of Eli Lilly and Novo Nordisk
Eli Lilly (LLY) and Novo Nordisk (NVO) have been large players for decades in the market for diabetes medications and are currently...
450
tim@emorningcoffee.com
Mar 127 min
Anti-obesity medications part 1: the market for anti-obesity drugs
This article is being published in instalments, of which this is the first, for context. INTRODUCTION Two macrotrends have been drivers...
1110
tim@emorningcoffee.com
Mar 54 min
Revisiting gold as an asset class
This is a guest post about gold, penned by online investment firm BullionVault. Gold has just pierced $2,100/oz, reaching a record high.
890
tim@emorningcoffee.com
Feb 279 min
Berkshire Hathaway: 2023 results and the path forward
Berkshire Hathaway released its FY earnings on Sat. As always, there are plenty of juicy nuggets to digest.
1500
tim@emorningcoffee.com
Feb 205 min
Revisiting semi-conductors
This article takes a quick look at the semi-conductor value-chain, including chip designers, fabricators and chip machinery makers.
700
tim@emorningcoffee.com
Feb 147 min
Enhancing shareholder value
Looks at ways companies can maximise shareholder value (aside from uttering the words “AI”) including dividends, stock buybacks & layoffs
540
tim@emorningcoffee.com
Jan 256 min
Portfolio update Dec 31, 2023 (4Q23 and FY 2023)
This article provides a 4Q23 update on my personal portfolio. I was conservatively positioned going into an unexpectedly strong quarter.
830
tim@emorningcoffee.com
Jan 231 min
Some investment "thoughts" to start off the new year
2023 was an amazing year for nearly all traditional asset classes around the world. Can this carry-on? This article covers my thoughts.
1920
Home: Blog2
bottom of page